60¢sixtycents

Takeda Pharmaceutical Company LimitedTAK

Is TAK cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$18.26+0.15 (+0.83%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$59B
Large-cap
-19%
2016 — today
10-Year Price
-21%
2016 — today
52-Week Range
$13.23$18.80
Current $18.26· 90%

Takeda Pharmaceutical, established in 1781 and based in Tokyo, is a global biopharmaceutical firm focused on the discovery, development, and commercialization of medicines. Its portfolio targets gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience, featuring brands like Entyvio, Takhzyro, and Vyvanse. Takeda maintains a vast international footprint and drives innovation through extensive strategic partnerships and licensing agreements with numerous research institutions and biotech firms.

Similar companies

Healthcare companies of comparable size to TAK
CompanyP/EDiv yield
CAHCardinal Health, Inc.32.40.9%
CORCencora, Inc.23.90.8%
ARGXargenx SE28.0—
BSXBoston Scientific Corporation17.5—
HUMHumana Inc.38.80.9%
BDXBecton, Dickinson and Company53.62.2%
EWEdwards Lifesciences Corporation48.5—
NTRANatera, Inc.-241.9—

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
49.6
Historically pricey
Historically pricey — last 10 years
Sector median 24.4above sector
P/B ratio
1.2
Above average
Pricier than usual over the last 10 years
Sector median 2.5below sector
EV / EBITDA
10.6
Above average
Pricier than usual over the last 10 years
Sector median 15.2below sector
Dividend Yield
3.4%
Historically low
Historically low relative to the last 10 years
Sector median 1.7%above sector
FCF Yield
6.2%
Around average
Around the 10-year average
Sector median -9.6%above sector
Free · No credit card needed

Get alerted when TAK is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.